A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

Clinical trial NCT07327359 · RECRUITING

Trial details

NCT number: NCT07327359
Sponsor: Olix Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Androgenetic Alopecia (AGA)

Start date: 2025-12-04
Primary completion: 2026-04-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.